Pick the relation: C = C₀·e−kt, LD = Vd·C/(S·F), maintenance rate = CL·Css/(S·F), τ = ln(Cpeak/Ctrough)/k.
For kidney function, estimate CrCl with Cockcroft–Gault first, then scale the dose or the interval.
Check the result: levels fall by half every half-life, and steady state takes about five half-lives.
2Practice problems
1.PharmacologyMedium
Which adverse effect of doxorubicin requires monitoring of heart function?
ASevere hypertension during the infusion itself
BPericarditis caused by infection
CRapid rise in cholesterol
DCumulative heart muscle damage leading to heart failure
2.PharmacologyHard
A patient on lisinopril for hypertension starts taking ibuprofen every day for knee pain. What is the main concern?
AA large fall in blood pressure, with fainting and falls on standing up
BFaster liver metabolism of lisinopril, so it stops working
CWeaker blood pressure control, kidney injury and high potassium
DA higher risk of a dry cough than with lisinopril alone
3.Dosage calculationsMedium
An ampoule of epinephrine (adrenaline) is labelled 1:1000 (1 mg/mL). The prescription is 0.5 mg IM for anaphylaxis. What volume V do you draw up?
1:10000.5 mg
V = mL
4.Dosage calculationsHard
A patient weighs 169.4 lb. The prescription is 10 mg/kg as a single dose, and the stock contains 250 mg in 5 mL. Using 1 kg = 2.2 lb, what volume V do you give?
169.4 lb10 mg/kg250 mg/5 mL1 kg = 2.2 lb
V = mL
5.Clinical pharmacokineticsMedium
Practice exercise (made-up values, not clinical guidance). After an IV dose of tobramycin, the level is 10 mg/L at 1 h and 5 mg/L at 4 h. Assume first-order elimination. Find the half-life t½.
C1 = 10 mg/L (1 h)C2 = 5 mg/L (4 h)
t½ = h
6.Clinical pharmacokineticsHard
Practice exercise (made-up values, not clinical guidance). A 97 kg patient takes oral theophylline (F = 1) every 12 h. The clearance is 0.03 L/kg/h. What dose D in mg gives an average steady-state level of 12 mg/L?
Answer: D · Cumulative heart muscle damage leading to heart failure
Why this is the answer
Anthracyclines such as doxorubicin can damage heart muscle, and the risk increases with cumulative dose. Heart function is assessed before and during treatment; the drug can also turn urine red.
Answer
D · Cumulative heart muscle damage leading to heart failure
2.Pharmacology
Answer: C · Weaker blood pressure control, kidney injury and high potassium
Why this is the answer
NSAIDs block prostaglandins that dilate the afferent arteriole and promote sodium loss. With an ACE inhibitor this can reduce blood pressure control and cause kidney injury and hyperkalaemia, especially if a diuretic is also used.
Answer
C · Weaker blood pressure control, kidney injury and high potassium
3.Dosage calculations
Answer: V = 0.5 mL
Solution strengths: a percentage strength is grams per 100 mL, so 1% = 1 g/100 mL = 10 mg/mL. A ratio strength 1:1000 means 1 g in 1000 mL = 1 mg/mL; 1:10 000 is 0.1 mg/mL. For a dilution the amount of drug stays the same: C₁·V₁ = C₂·V₂.
Concentration
1:1000 = 1 g/1000 mL = 1 mg/mL
Volume
V = 0.5/1 = 0.5 mL
Answer
V = 0.5 mL
US labels now state mg/mL (1 mg/mL = 1:1000; 0.1 mg/mL = 1:10 000). Never give 1 mg/mL epinephrine IV push.
4.Dosage calculations
Answer: V = 15.4 mL
Dose calculation: the amount to give equals what is prescribed divided by what you have, times the quantity it comes in: amount = (desired dose/stock strength) × stock volume. Always keep the units the same (convert g to mg, mg to mcg first) and check that the answer is sensible.
Weight in kg
169.4/2.2 = 77 kg
Dose
10·77 = 770 mg
Volume
V = (770/250)·5 = 15.4 mL
Answer
V = 15.4 mL
5.Clinical pharmacokinetics
Answer: t½ = 3 h
Clearance and volume: at steady state the dosing rate equals the elimination rate, so the maintenance rate = CL × Css. A loading dose is LD = Vd × C/(S × F), with S the salt factor (fraction of active drug in the salt) and F the bioavailability (1 for IV). From two levels, k = ln(C₁/C₂)/Δt; for an IV bolus Vd = dose/C₀ and CL = k × Vd. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Elimination rate constant
k = ln(10/5)/3 = 0.6931/3 = 0.231 h⁻¹
Half-life
t½ = 0.693/0.231 = 3 h
Answer
t½ = 3 h
6.Clinical pharmacokinetics
Answer: D = 419 mg
Designing a regimen: with rapid IV doses the level falls from peak to trough during the interval, so τ = ln(Cpeak/Ctrough)/k and the dose that restores the peak is Vd × (Cpeak − Ctrough). The average steady-state level is Css,avg = S·F·dose/(CL·τ). An infusion rises as C = (R/CL)(1 − e−kt). For a drug cleared by the kidneys, the dose is scaled with the creatinine clearance. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Clearance
CL = 0.03·97 = 2.91 L/h
Dose
D = Css,avg·CL·τ/(S·F) = 12·2.91·12/(1·1) = 419 mg